%0 Journal Article
%A Freitag, Martin
%A Radtke, Jan Philipp
%A Hadaschik, Boris A
%A Kopp-Schneider, Annette
%A Eder, Matthias
%A Kopka, Klaus
%A Haberkorn, Uwe
%A Röthke, Matthias
%A Schlemmer, Heinz-Peter
%A Afshar-Oromieh, Ali
%T Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer.
%J European journal of nuclear medicine and molecular imaging
%V 43
%N 1
%@ 1619-7089
%C Heidelberg [u.a.]
%I Springer-Verl.
%M DKFZ-2017-01972
%P 70 - 83
%D 2016
%X To evaluate the reproducibility of the combination of hybrid PET/MRI and the (68)Ga-PSMA-11 tracer in depicting lymph node (LN) and bone metastases of prostate cancer (PC) in comparison with that of PET/CT.A retrospective analysis of 26 patients who were subjected to (68)Ga-PSMA PET/CTlow-dose (1 h after injection) followed by PET/MRI (3 h after injection) was performed. MRI sequences included T1-w native, T1-w contrast-enhanced, T2-w fat-saturated and diffusion-weighted sequences (DWIb800). Discordant PET-positive and morphological findings were evaluated. Standardized uptake values (SUV) of PET-positive LNs and bone lesions were quantified and their morphological size and conspicuity determined.Comparing the PET components, the proportion of discordant PSMA-positive suspicious findings was very low (98.5 
%K Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC)) (NLM Chemicals)
%K Oligopeptides (NLM Chemicals)
%K Edetic Acid (NLM Chemicals)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:26508290
%R 10.1007/s00259-015-3206-3
%U https://inrepo02.dkfz.de/record/125848